K. Kostbade

Phosphorylation of p70 Ribosomal Protein S6 Kinase &bgr;‐1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer

M. Schuler, K. Schmid, K. Worm, 2018, Clinical colorectal cancer.

Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients

N. Hirmas, K. Herrmann, M. Schuler, 2021, The Journal of Nuclear Medicine.

Multimodal survival prediction in advanced pancreatic cancer using machine learning

K. Schmid, M. Sinn, M. Wiesweg, 2022, ESMO open.

Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.

M. Schuler, K. Schmid, K. Worm, 2020, Clinical colorectal cancer.

A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma

S. Ting, M. Wiesweg, B. Schumacher, 2022, Journal of Cancer Research and Clinical Oncology.

Plasma Sequencing for Patients with GIST—Limitations and Opportunities in an Academic Setting

J. Köster, T. Herold, K. Kostbade, 2022, Cancers.

Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities

L. Umutlu, M. Schuler, K. Kostbade, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas.

K. Darwiche, M. Schuler, K. Schmid, 2015, Lung cancer.

Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols

S. Ting, M. Wiesweg, B. Schumacher, 2023, Oncology Research and Treatment.

Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting

M. Wiesweg, M. Goetz, T. Herold, 2023, Journal of Cancer Research and Clinical Oncology.